Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma Academic Article uri icon

authors

  • Cebon, J
  • Jäger, E
  • Shackleton, MJ
  • Gibbs, P
  • Davis, ID
  • Hopkins, W
  • Gibbs, S
  • Chen, Q
  • Karbach, J
  • Jackson, H
  • MacGregor, DP
  • Sturrock, S
  • Vaughan, H
  • Maraskovsky, E
  • Neumann, A
  • Hoffman, E
  • Sherman, ML
  • Knuth, A

publication date

  • July 16, 2003